发明名称 |
USE OF RANK/RANKL ANTAGONISTS FOR TREATING NEUROMUSCULAR DISORDERS, GENETIC MYOPATHIES AND/OR NON GENETIC MYOPATHIES AND/OR FOR REGULATING SKELETAL AND CARDIAC MUSCLE DISUSE, DISEASES AND AGING |
摘要 |
<p>A pharmaceutical composition includes one or more RANK/RANKL antagonists and a pharmaceutically acceptable carrier. The composition can be used for treating neuromuscular disorders, non-genetic myopathies, or genetic myopathies; maintaining and/or preserving the excitation:contraction:relaxation coupling; reducing loss of muscle strength associated with neuromuscular disorders, non-genetic myopathies or genetic myopathies; reducing the loss of muscular strength associated with skeletal or cardiac muscle disuse, diseases and aging; or regulating skeletal or cardiac muscle disuse, diseases and/or aging in a patient in need thereof. Methods are used to identify candidate compounds.</p> |
申请公布号 |
EP2776066(A1) |
申请公布日期 |
2014.09.17 |
申请号 |
EP20120847546 |
申请日期 |
2012.11.06 |
申请人 |
UNIVERSITÉ LAVAL |
发明人 |
FRENETTE, JÉRÔME;PENNINGER, JOSEF |
分类号 |
A61K39/395;A61K31/7105;A61K38/19;A61P21/00;G01N33/48;G01N33/53 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|